This is the authors' abstract. We don't add key points for this paper.
This paper presents an ISO FORTRAN subroutine for determining the required sample size or power in a stratified clinical trial. The algorithm permits a post-accrual follow up period, censored observations, patient strata or risk groups, and unequal case allocation schemes. An example which illustrates use of the subroutine is provided.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bernstein et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: